Therapeutic Monoclonal Antibodies: Clinical Applications

Yanjie Sun, Zhuoyun Wan, Zixiao Zhang

2022

Abstract

Diagnostic and therapeutic monoclonal antibodies (mAbs) have a broad application prospect, conducive to mass production by optimizing the quality of monoclonal antibodies and improving productivity. The number of monoclonal antibodies approved for the treatment and use has increased significantly over the years. Some improvements and modifications have been made given monoclonal antibody’s side effects and limitations. These improvements facilitate monoclonal antibodies in various therapeutic applications, from treating noncontagious diseases such as cancer, like breast cancer, to using monoclonal antibodies to cure infectious diseases caused by viruses, such as viruses Covid-19 and its causing agent SARS-CoV-2. This paper reviews monoclonal antibody’s clinical application, focusing on these two main categories and discussing its potential future development trend.

Paper Citation

in Harvard Style

Sun Y., Wan Z. and Zhang Z. (2022). Therapeutic Monoclonal Antibodies: Clinical Applications. In Proceedings of the 4th International Conference on Biotechnology and Biomedicine - Volume 1: ICBB; ISBN 978-989-758-637-8, SciTePress, pages 335-342. DOI: 10.5220/0012020800003633

in Bibtex Style

@conference{icbb22,
author={Yanjie Sun and Zhuoyun Wan and Zixiao Zhang},
title={Therapeutic Monoclonal Antibodies: Clinical Applications},
booktitle={Proceedings of the 4th International Conference on Biotechnology and Biomedicine - Volume 1: ICBB},
year={2022},
pages={335-342},
publisher={SciTePress},
organization={INSTICC},
doi={10.5220/0012020800003633},
isbn={978-989-758-637-8},
}

in EndNote Style

TY - CONF

JO - Proceedings of the 4th International Conference on Biotechnology and Biomedicine - Volume 1: ICBB
TI - Therapeutic Monoclonal Antibodies: Clinical Applications
SN - 978-989-758-637-8
AU - Sun Y.
AU - Wan Z.
AU - Zhang Z.
PY - 2022
SP - 335
EP - 342
DO - 10.5220/0012020800003633
PB - SciTePress